PLX NYSE · Healthcare · FY 2025-12-31

Protalix BioTherapeutics, Inc.

0.00.61.31.92.6ABVfair 0.60buy —EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 2.37 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
2.370 USD
Market cap
190.6M USD
P / B
3.95
P / E
EPS
-0.080
DPS / yield
(0.0%)
NAV / share
0.600
Graham number
Z'' score
-10.92
Piotroski F
1 / 9
Beneish M
-0.26
ROIC vs WACC
-9.6% vs 11.1%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.